There is no cure for baldness. No treatment can permanently restore a full head of hair or switch off the genetic programming that causes follicles to shrink. But several options can slow hair loss, thicken remaining hair, or relocate follicles that are resistant to thinning. The gap between “cure” and “effective management” has narrowed considerably, and a few experimental approaches are targeting the biology of hair growth in ways that weren’t possible a decade ago.
Why Hair Loss Happens in the First Place
The most common form of hair loss, androgenetic alopecia, affects roughly 50% of men by age 50 and a significant number of women as well. It’s driven by a hormone called DHT, which is created when an enzyme converts testosterone into a more potent form. DHT itself isn’t the problem for most people. The problem is that some hair follicles are genetically programmed to be sensitive to it.
When DHT binds to receptors on those vulnerable follicles, it triggers a chain of cellular responses that shrinks the follicle over time, a process called miniaturization. Each hair growth cycle gets shorter. The hairs that emerge become thinner, lighter, and shorter until eventually the follicle produces only a fine, nearly invisible strand or stops producing visible hair altogether. This process is gradual, which is why hair loss often takes years to become noticeable, and why early intervention tends to produce better results than waiting.
What FDA-Approved Treatments Actually Do
Two medications have decades of evidence behind them. Minoxidil (the active ingredient in Rogaine) is a topical treatment that increases blood flow to follicles and extends the growth phase of the hair cycle. It doesn’t block DHT. It works by keeping existing follicles productive for longer and can modestly increase hair density, but it requires continuous daily use. Stop applying it, and any gains reverse within a few months.
Finasteride (Propecia) takes a different approach. It blocks the enzyme that converts testosterone into DHT, reducing DHT levels by roughly 60 to 70%. This slows or stops further miniaturization in most men who take it, and some see partial regrowth. Like minoxidil, the effects last only as long as you keep taking the pill. Neither drug is a cure because neither changes the underlying genetic sensitivity of your follicles. They manage the condition the way blood pressure medication manages hypertension: effectively, but not permanently.
Hair Transplants: Permanent but Limited
Hair transplant surgery is the closest thing to a lasting solution, though calling it a “cure” would be misleading. The procedure moves follicles from the back and sides of the scalp (areas genetically resistant to DHT) to thinning areas on top. Because those transplanted follicles retain their resistance, the relocated hair typically continues growing for life.
Two main techniques exist. Follicular unit transplantation (FUT) removes a thin strip of scalp from the donor area, and individual follicular units are dissected under a microscope. Follicular unit excision (FUE) extracts individual follicle groups using tiny circular punches, leaving no linear scar. A side-by-side study published in the Hair Transplant Forum International found that for all practical purposes, FUE and FUT produced equal results in both graft survival and hair yield, with only about a 1% difference in graft survival and a 6% difference in hair yield slightly favoring FUE.
The limitation is supply. You have a finite number of donor follicles, and severe baldness may require more coverage than available donor hair can provide. Most procedures involve 2,000 or more grafts and cost between $6,000 and $12,000 on average, though prices vary widely by city. In places like Chicago or Los Angeles, costs can reach $17,000 to $20,000. Insurance almost never covers it. Many patients also need to continue using finasteride or minoxidil after surgery to protect the non-transplanted hair that remains vulnerable to DHT.
PRP: A Middle Ground With Growing Evidence
Platelet-rich plasma therapy, or PRP, involves drawing your blood, concentrating the platelets, and injecting the resulting solution into the scalp. The growth factors in the concentrated platelets appear to stimulate follicle activity and push resting follicles back into a growth phase.
The evidence for PRP has strengthened over the past several years. Multiple clinical trials have found statistically significant increases in hair count, density, and thickness compared to placebo injections. One study showed a mean hair density improvement of about 23 hairs per square centimeter roughly a year after the last injection. Others have documented measurable increases in hair thickness within four weeks that persisted for months. When PRP was combined with minoxidil, the combination outperformed either treatment alone, and PRP on its own was more effective than minoxidil at increasing average hair diameter and reducing the proportion of fine, wispy hairs.
PRP is not a permanent fix. Most protocols involve a series of initial sessions followed by maintenance treatments every six to twelve months. It works best for people with thinning hair rather than completely bald areas, since it relies on reviving dormant follicles rather than creating new ones.
What’s in the Research Pipeline
The most promising leads for a true cure involve understanding the signaling molecules that tell follicles to grow or rest. Researchers at UC Irvine identified a protein called SCUBE3 that acts as a growth-activating signal within hair follicles. In normal skin, this protein appears only in the base of actively growing follicles and is absent during resting phases. When researchers injected SCUBE3 into mouse skin, it was sufficient to trigger new hair growth. Importantly, the growth-activating effect was partially conserved in human scalp follicles, meaning the same biological machinery exists in people.
This line of research is still preclinical, meaning it hasn’t been tested as a treatment in humans yet. But it represents a shift in strategy. Rather than blocking DHT or relocating resistant follicles, the goal is to directly reactivate the follicle’s own growth program. If that approach works at scale, it would be far closer to a genuine cure than anything currently available.
Other experimental approaches include antibodies targeting hormonal pathways involved in hair cycling. A clinical trial for one such antibody, HMI-115, which targets prolactin receptors in men with androgenetic alopecia, completed in late 2024. Results have not yet been widely published, but the fact that novel biological targets are reaching completed trials marks real progress in the field.
Practical Expectations for Right Now
If you’re experiencing hair loss today, the realistic picture looks like this: you can slow or stop further loss with medication, partially restore density with transplant surgery or PRP, and maintain those results indefinitely with ongoing treatment. The earlier you start, the more hair you have to work with. A person who begins finasteride at the first signs of thinning will generally preserve far more hair over the following decade than someone who waits until significant loss has occurred.
The total cost of managing hair loss adds up. Finasteride and minoxidil run a few hundred dollars per year. PRP sessions typically cost $500 to $1,500 each, with multiple sessions needed. A transplant is a one-time expense in the thousands, but often not truly one-time if you need a second procedure years later or continue medications to protect the remaining native hair. None of these costs are typically covered by insurance.
A cure in the traditional sense, one treatment that permanently reverses baldness, does not exist yet. But the combination of current options can produce results that would have been unrecognizable a generation ago, and the science of follicle biology is closer than ever to cracking the problem at its root.